NCI Phase II grant for development of a platform for integrative data analysis in cancer

June 22, 2010

By hammersmith

[Source: Digital Journal] – GeneGo, Inc., a leading provider of databases, software and services in systems biology and chemistry, announced today that they were awarded with a Phase II SBIR grant from the National Cancer Institute (NCI) for further development of an analytical platform for translational research and data analysis in oncology. NCI funding will support the industry and academia collaborative project MetaMiner (Oncology) run by GeneGo with investigators at Harvard Medical School, Johns Hopkins University, Tgen, Van Andel Institute and several global pharmaceutical companies. The MetaMiner platform combines disease reconstruction of multiple cancers, OMICs data repository and advanced statistical tools based on pathway descriptors.

For more information: GeneGo is Awarded NCI Phase II Grant for Development of a Platform for Integrative Data Analysis in Cancer